CareLit Fachartikel

Botulinum Toxin for Chronic Lateral Epicondylitis (LE)

Grüner, S.; Schulz, A.; Schlüter-Brust, K.; Lippert-Grüner, M. · NeuroTransmitter · 2021 · Heft 05 · S. 554 bis 564

Dokument
641847
CareLit-ID
Jahr
2021
Publikation
PDF
nein
Metadaten
DOI
ja
zitierfähig

Bibliografische Angaben

Zeitschrift
NeuroTransmitter
Autor:innen
Grüner, S.; Schulz, A.; Schlüter-Brust, K.; Lippert-Grüner, M.
Ausgabe
Heft 05 / 2021
Jahrgang 159
Seiten
554 bis 564
Erschienen: 2021-10-01 00:00:00
ISSN
1864-6697;1864-6743

Zusammenfassung

AbstractLateral epicondylitis is a common disease in orthopaedic practice. Although the majority of cases do not become chronic, patients who do not respond to the initial treatment may suffer from pain in the long term and effective treatment is challenging. The off-label use of botulinum toxin is one of the common potential indications for the substance in orthopaedics and traumatology. In a literature review of 2000 – 2019, eight EBM ≥ level 3 studies evaluating the use of botulinum toxin in lateral epicondylitis were found. Five of these studies evaluated botulinum toxin versus placebo in chronic cases; two…

Schlagworte

After NeuroTransmitter